MIT researchers introduce Boltz-1, a fully open-source model for predicting biomolecular structures
With models like AlphaFold3 limited to academic research, the team built an equivalent alternative, to encourage innovation more broadly.
With models like AlphaFold3 limited to academic research, the team built an equivalent alternative, to encourage innovation more broadly.
In a recent commentary, a team from MIT, Equality AI, and Boston University highlights the gaps in regulation for AI models and non-AI algorithms in health care.
In a talk at MIT, White House science advisor Arati Prabhakar outlined challenges in medicine, climate, and AI, while expressing resolve to tackle hard problems.
Researchers argue that in health care settings, “responsible use” labels could ensure AI systems are deployed appropriately.
The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.
Fifteen new faculty members join six of the school’s academic departments.
Ashutosh Kumar, a materials science and engineering PhD student and MathWorks Fellow, applies his eclectic skills to studying the relationship between bacteria and cancer.
Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.
MIT.nano Immersion Lab works with AR/VR startup to create transcontinental medical instruction.
Using a machine-learning algorithm, researchers can predict interactions that could interfere with a drug’s effectiveness.